Latest Update: Impact of current COVID-19 situation has been considered in this report while making the analysis.
Global Clinical Chemistry Devises for Laboratory Animal Models Market by Type (Albumin Analyzers, Cardiac Marker Analyzers, Clinical Chemistry Analyzers, CO-Oximeter, Creatinine Analyzer, Others), By Application (Laboratory, University, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030-report

Global Clinical Chemistry Devises for Laboratory Animal Models Market by Type (Albumin Analyzers, Cardiac Marker Analyzers, Clinical Chemistry Analyzers, CO-Oximeter, Creatinine Analyzer, Others), By Application (Laboratory, University, Others) and Region (North America, Latin America, Europe, Asia Pacific and Middle East & Africa), Forecast From 2022 To 2030

Report ID: 234584 4200 Medical Devices & Consumables 377 143 Pages 4.6 (33)
                                          

Market Overview:


The global clinical chemistry devices for laboratory animal models market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The market growth can be attributed to the increasing demand for preclinical research and rising number of CRO/CMOs. In addition, technological advancements in clinical chemistry devices are also propelling the growth of this market. However, stringent regulatory norms and high cost of instruments are restraining the growth of this market. Based on type, the global clinical chemistry devices for laboratory animal models market is segmented into albumin analyzers, cardiac marker analyzers, clinical chemistry analyzers, CO-oximeter and creatinine analyzer. Albumin analyzers held a major share in 2017 owing to their wide usage in preclinical research studies across different application areas such as university laboratories and contract research organizations (CROs). Cardiac markeranalyzers are expected to grow at a highest CAGR during the forecast period due its growing demand from pharmaceutical companies for drug discovery purposes.


Global Clinical Chemistry Devises for Laboratory Animal Models Industry Outlook


Product Definition:


Clinical chemistry devices for laboratory animal models are used to measure various chemical compounds in the blood, including proteins, enzymes, and lipids. These devices can help researchers determine how different drugs or treatments may affect these compounds and how they may interact with each other. The importance of clinical chemistry devices for laboratory animal models is that they can help researchers better understand the effects of drugs or treatments on human health.


Albumin Analyzers:


Albumin is a type of protein, found in the blood. It helps maintain the fluid balance and helps control bleeding. The normal range for human albumin varies between 40-80 gm per L of blood. Albumin level below 40 gm per L is considered to be low, while levels above 80 gm per L are considered to be high.


Cardiac Marker Analyzers:


Cardiac marker analyzers are devices that are used to measure the heart rate of patients during or after exercise, surgery, or trauma. The data obtained from these markers helps in monitoring the extent of myocardial ischemia and infarction as well as in identifying individuals at risk for developing cardiovascular diseases.


These devices have gained immense popularity among researchers and scientists due to their ability to provide accurate results with higher sensitivity.


Application Insights:


The laboratory application segment dominated the global market in 2017. This is attributed to the rising usage of clinical chemistry analyzers for routine testing in laboratories. In addition, a growing number of research studies that involve laboratory animal models and require various types of clinical chemistry analyzers are expected to propel product demand over the forecast period.


For instance, according to an article published by Clinical Chemistry Journal (CCJ), it was reported that around 85% of new drug applications are rejected due to non-clinical toxicology tests results. Similarly, another study states that out of 10 drugs developed, 9 fail because they were found toxic or not effective on human body in trials conducted with animals only. Such statistics indicate a high need for novel drug development which requires large scale animal testing which eventually leads to increased demand for clinical chemistry analyzers across laboratories worldwide.


Regional Analysis:


North America dominated the global market in 2017. This is due to the presence of a large number of animal testing laboratories and increasing demand for laboratory animal tests in this region. Moreover, increasing R&D expenditure by government agencies and private companies for developing advanced diagnostic products is also one of the major factors contributing to regional growth. For instance, as per an article published in Trends Biotechnology, U.S.-based company invested around USD X million from 2000 to 2014 on R&D related to laboratory animals while another study showed that total spending on biomedical research by U.S.-based companies was around USD X billion (in 2015).


Growth Factors:


  • Increasing demand for preclinical research services by the pharmaceutical and biotechnology industries is expected to drive the growth of the global clinical chemistry devices for laboratory animal models market during the forecast period.
  • The increasing use of laboratory animals in drug discovery and development processes is another major factor that is anticipated to fuel the demand for clinical chemistry devices for laboratory animal models during the forecast period.
  • The rising number of CRO (contract research organizations) and CMOs (contract manufacturing organizations) is also projected to boost the growth of this market in near future.
  • Growing investments by key players in R&D activities are also expected to propel market growth over next few years. For instance, In March 2017, Siemens Healthineers announced plans to invest around €200 million (~US6 million) in R&D over next three years with a focus on developing new products and expanding its presence in emerging markets such as China, India, Brazil, and Russia). This would help create new opportunities for players operating in this market space. 5 Emerging technologies such as microfluidics are likely to offer lucrative opportunities for players operating in this market space over next few years

Scope Of The Report

Report Attributes

Report Details

Report Title

Clinical Chemistry Devises for Laboratory Animal Models Market Research Report

By Type

Albumin Analyzers, Cardiac Marker Analyzers, Clinical Chemistry Analyzers, CO-Oximeter, Creatinine Analyzer, Others

By Application

Laboratory, University, Others

By Companies

Hitachi, STARR Life Sciences, Roche, Abbott Point of Care, Diatron, Olympus, Alfa Wassermann, Beckman, Acuvet Biotech, Hitachi

Regions Covered

North America, Europe, APAC, Latin America, MEA

Base Year

2021

Historical Year

2019 to 2020 (Data from 2010 can be provided as per availability)

Forecast Year

2030

Number of Pages

143

Number of Tables & Figures

101

Customization Available

Yes, the report can be customized as per your need.


Global Clinical Chemistry Devises for Laboratory Animal Models Market Report Segments:

The global Clinical Chemistry Devises for Laboratory Animal Models market is segmented on the basis of:

Types

Albumin Analyzers, Cardiac Marker Analyzers, Clinical Chemistry Analyzers, CO-Oximeter, Creatinine Analyzer, Others

The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.

Applications

Laboratory, University, Others

The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.

Some of the companies that are profiled in this report are:

  1. Hitachi
  2. STARR Life Sciences
  3. Roche
  4. Abbott Point of Care
  5. Diatron
  6. Olympus
  7. Alfa Wassermann
  8. Beckman
  9. Acuvet Biotech
  10. Hitachi

Global Clinical Chemistry Devises for Laboratory Animal Models Market Overview


Highlights of The Clinical Chemistry Devises for Laboratory Animal Models Market Report:

  1. The market structure and projections for the coming years.
  2. Drivers, restraints, opportunities, and current trends of market.
  3. Historical data and forecast.
  4. Estimations for the forecast period 2030.
  5. Developments and trends in the market.
  6. By Type:

    1. Albumin Analyzers
    2. Cardiac Marker Analyzers
    3. Clinical Chemistry Analyzers
    4. CO-Oximeter
    5. Creatinine Analyzer
    6. Others
  1. By Application:

    1. Laboratory
    2. University
    3. Others
  1. Market scenario by region, sub-region, and country.
  2. Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
  3. Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
  4. Government Policies, Macro & Micro economic factors are also included in the report.

We have studied the Clinical Chemistry Devises for Laboratory Animal Models Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.

Regional Analysis

  • North America
  • Europe
  • Asia Pacific
  • Middle East & Africa
  • Latin America

Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.

The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.

How you may use our products:

  • Correctly Positioning New Products
  • Market Entry Strategies
  • Business Expansion Strategies
  • Consumer Insights
  • Understanding Competition Scenario
  • Product & Brand Management
  • Channel & Customer Management
  • Identifying Appropriate Advertising Appeals

Global Clinical Chemistry Devises for Laboratory Animal Models Market Statistics

8 Reasons to Buy This Report

  1. Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
  2. Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
  3. Implemented Robust Methodology to Prepare the Report
  4. Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
  5. Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
  6. Provides Information About the Top-winning Strategies Implemented by Industry Players.
  7. In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
  8. Customization of the Report Available

Frequently Asked Questions?


There are a variety of Clinical Chemistry Devises for Laboratory Animal Models that can be used to help researchers study the effects of drugs and other substances on animals. These include studies that look at how different drugs affect blood chemistry, heart function, liver function, and more.

Some of the major players in the clinical chemistry devises for laboratory animal models market are Hitachi, STARR Life Sciences, Roche, Abbott Point of Care, Diatron, Olympus, Alfa Wassermann, Beckman, Acuvet Biotech, Hitachi.

The clinical chemistry devises for laboratory animal models market is expected to grow at a compound annual growth rate of 5.5%.

                                            
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Clinical Chemistry Devises for Laboratory Animal Models Market Overview    4.1 Introduction       4.1.1 Market Taxonomy       4.1.2 Market Definition       4.1.3 Macro-Economic Factors Impacting the Market Growth    4.2 Clinical Chemistry Devises for Laboratory Animal Models Market Dynamics       4.2.1 Market Drivers       4.2.2 Market Restraints       4.2.3 Market Opportunity    4.3 Clinical Chemistry Devises for Laboratory Animal Models Market - Supply Chain Analysis       4.3.1 List of Key Suppliers       4.3.2 List of Key Distributors       4.3.3 List of Key Consumers    4.4 Key Forces Shaping the Clinical Chemistry Devises for Laboratory Animal Models Market       4.4.1 Bargaining Power of Suppliers       4.4.2 Bargaining Power of Buyers       4.4.3 Threat of Substitution       4.4.4 Threat of New Entrants       4.4.5 Competitive Rivalry    4.5 Global Clinical Chemistry Devises for Laboratory Animal Models Market Size & Forecast, 2018-2028       4.5.1 Clinical Chemistry Devises for Laboratory Animal Models Market Size and Y-o-Y Growth       4.5.2 Clinical Chemistry Devises for Laboratory Animal Models Market Absolute $ Opportunity

Chapter 5 Global Clinical Chemistry Devises for Laboratory Animal Models Market Analysis and Forecast by Type
   5.1 Introduction
      5.1.1 Key Market Trends & Growth Opportunities by Type
      5.1.2 Basis Point Share (BPS) Analysis by Type
      5.1.3 Absolute $ Opportunity Assessment by Type
   5.2 Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Type
      5.2.1 Albumin Analyzers
      5.2.2 Cardiac Marker Analyzers
      5.2.3 Clinical Chemistry Analyzers
      5.2.4 CO-Oximeter
      5.2.5 Creatinine Analyzer
      5.2.6 Others
   5.3 Market Attractiveness Analysis by Type

Chapter 6 Global Clinical Chemistry Devises for Laboratory Animal Models Market Analysis and Forecast by Applications
   6.1 Introduction
      6.1.1 Key Market Trends & Growth Opportunities by Applications
      6.1.2 Basis Point Share (BPS) Analysis by Applications
      6.1.3 Absolute $ Opportunity Assessment by Applications
   6.2 Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Applications
      6.2.1 Laboratory
      6.2.2 University
      6.2.3 Others
   6.3 Market Attractiveness Analysis by Applications

Chapter 7 Global Clinical Chemistry Devises for Laboratory Animal Models Market Analysis and Forecast by Region
   7.1 Introduction
      7.1.1 Key Market Trends & Growth Opportunities by Region
      7.1.2 Basis Point Share (BPS) Analysis by Region
      7.1.3 Absolute $ Opportunity Assessment by Region
   7.2 Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Region
      7.2.1 North America
      7.2.2 Europe
      7.2.3 Asia Pacific
      7.2.4 Latin America
      7.2.5 Middle East & Africa (MEA)
   7.3 Market Attractiveness Analysis by Region

Chapter 8 Coronavirus Disease (COVID-19) Impact 
   8.1 Introduction 
   8.2 Current & Future Impact Analysis 
   8.3 Economic Impact Analysis 
   8.4 Government Policies 
   8.5 Investment Scenario

Chapter 9 North America Clinical Chemistry Devises for Laboratory Animal Models Analysis and Forecast
   9.1 Introduction
   9.2 North America Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Country
      9.2.1 U.S.
      9.2.2 Canada
   9.3 Basis Point Share (BPS) Analysis by Country
   9.4 Absolute $ Opportunity Assessment by Country
   9.5 Market Attractiveness Analysis by Country
   9.6 North America Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Type
      9.6.1 Albumin Analyzers
      9.6.2 Cardiac Marker Analyzers
      9.6.3 Clinical Chemistry Analyzers
      9.6.4 CO-Oximeter
      9.6.5 Creatinine Analyzer
      9.6.6 Others
   9.7 Basis Point Share (BPS) Analysis by Type 
   9.8 Absolute $ Opportunity Assessment by Type 
   9.9 Market Attractiveness Analysis by Type
   9.10 North America Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Applications
      9.10.1 Laboratory
      9.10.2 University
      9.10.3 Others
   9.11 Basis Point Share (BPS) Analysis by Applications 
   9.12 Absolute $ Opportunity Assessment by Applications 
   9.13 Market Attractiveness Analysis by Applications

Chapter 10 Europe Clinical Chemistry Devises for Laboratory Animal Models Analysis and Forecast
   10.1 Introduction
   10.2 Europe Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Country
      10.2.1 Germany
      10.2.2 France
      10.2.3 Italy
      10.2.4 U.K.
      10.2.5 Spain
      10.2.6 Russia
      10.2.7 Rest of Europe
   10.3 Basis Point Share (BPS) Analysis by Country
   10.4 Absolute $ Opportunity Assessment by Country
   10.5 Market Attractiveness Analysis by Country
   10.6 Europe Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Type
      10.6.1 Albumin Analyzers
      10.6.2 Cardiac Marker Analyzers
      10.6.3 Clinical Chemistry Analyzers
      10.6.4 CO-Oximeter
      10.6.5 Creatinine Analyzer
      10.6.6 Others
   10.7 Basis Point Share (BPS) Analysis by Type 
   10.8 Absolute $ Opportunity Assessment by Type 
   10.9 Market Attractiveness Analysis by Type
   10.10 Europe Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Applications
      10.10.1 Laboratory
      10.10.2 University
      10.10.3 Others
   10.11 Basis Point Share (BPS) Analysis by Applications 
   10.12 Absolute $ Opportunity Assessment by Applications 
   10.13 Market Attractiveness Analysis by Applications

Chapter 11 Asia Pacific Clinical Chemistry Devises for Laboratory Animal Models Analysis and Forecast
   11.1 Introduction
   11.2 Asia Pacific Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Country
      11.2.1 China
      11.2.2 Japan
      11.2.3 South Korea
      11.2.4 India
      11.2.5 Australia
      11.2.6 South East Asia (SEA)
      11.2.7 Rest of Asia Pacific (APAC)
   11.3 Basis Point Share (BPS) Analysis by Country
   11.4 Absolute $ Opportunity Assessment by Country
   11.5 Market Attractiveness Analysis by Country
   11.6 Asia Pacific Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Type
      11.6.1 Albumin Analyzers
      11.6.2 Cardiac Marker Analyzers
      11.6.3 Clinical Chemistry Analyzers
      11.6.4 CO-Oximeter
      11.6.5 Creatinine Analyzer
      11.6.6 Others
   11.7 Basis Point Share (BPS) Analysis by Type 
   11.8 Absolute $ Opportunity Assessment by Type 
   11.9 Market Attractiveness Analysis by Type
   11.10 Asia Pacific Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Applications
      11.10.1 Laboratory
      11.10.2 University
      11.10.3 Others
   11.11 Basis Point Share (BPS) Analysis by Applications 
   11.12 Absolute $ Opportunity Assessment by Applications 
   11.13 Market Attractiveness Analysis by Applications

Chapter 12 Latin America Clinical Chemistry Devises for Laboratory Animal Models Analysis and Forecast
   12.1 Introduction
   12.2 Latin America Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Country
      12.2.1 Brazil
      12.2.2 Mexico
      12.2.3 Rest of Latin America (LATAM)
   12.3 Basis Point Share (BPS) Analysis by Country
   12.4 Absolute $ Opportunity Assessment by Country
   12.5 Market Attractiveness Analysis by Country
   12.6 Latin America Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Type
      12.6.1 Albumin Analyzers
      12.6.2 Cardiac Marker Analyzers
      12.6.3 Clinical Chemistry Analyzers
      12.6.4 CO-Oximeter
      12.6.5 Creatinine Analyzer
      12.6.6 Others
   12.7 Basis Point Share (BPS) Analysis by Type 
   12.8 Absolute $ Opportunity Assessment by Type 
   12.9 Market Attractiveness Analysis by Type
   12.10 Latin America Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Applications
      12.10.1 Laboratory
      12.10.2 University
      12.10.3 Others
   12.11 Basis Point Share (BPS) Analysis by Applications 
   12.12 Absolute $ Opportunity Assessment by Applications 
   12.13 Market Attractiveness Analysis by Applications

Chapter 13 Middle East & Africa (MEA) Clinical Chemistry Devises for Laboratory Animal Models Analysis and Forecast
   13.1 Introduction
   13.2 Middle East & Africa (MEA) Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Country
      13.2.1 Saudi Arabia
      13.2.2 South Africa
      13.2.3 UAE
      13.2.4 Rest of Middle East & Africa (MEA)
   13.3 Basis Point Share (BPS) Analysis by Country
   13.4 Absolute $ Opportunity Assessment by Country
   13.5 Market Attractiveness Analysis by Country
   13.6 Middle East & Africa (MEA) Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Type
      13.6.1 Albumin Analyzers
      13.6.2 Cardiac Marker Analyzers
      13.6.3 Clinical Chemistry Analyzers
      13.6.4 CO-Oximeter
      13.6.5 Creatinine Analyzer
      13.6.6 Others
   13.7 Basis Point Share (BPS) Analysis by Type 
   13.8 Absolute $ Opportunity Assessment by Type 
   13.9 Market Attractiveness Analysis by Type
   13.10 Middle East & Africa (MEA) Clinical Chemistry Devises for Laboratory Animal Models Market Size Forecast by Applications
      13.10.1 Laboratory
      13.10.2 University
      13.10.3 Others
   13.11 Basis Point Share (BPS) Analysis by Applications 
   13.12 Absolute $ Opportunity Assessment by Applications 
   13.13 Market Attractiveness Analysis by Applications

Chapter 14 Competition Landscape 
   14.1 Clinical Chemistry Devises for Laboratory Animal Models Market: Competitive Dashboard
   14.2 Global Clinical Chemistry Devises for Laboratory Animal Models Market: Market Share Analysis, 2019
   14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy) 
      14.3.1 Hitachi
      14.3.2 STARR Life Sciences
      14.3.3 Roche
      14.3.4 Abbott Point of Care
      14.3.5 Diatron
      14.3.6 Olympus
      14.3.7 Alfa Wassermann
      14.3.8 Beckman
      14.3.9 Acuvet Biotech
      14.3.10 Hitachi

Our Trusted Clients

Contact Us